Lack of anti-factor Xa activity in umbilical cord vein samples after subcutaneous administration of heparin or low molecular mass heparin in pregnant women
- PMID: 8034237
- DOI: 10.1159/000216894
Lack of anti-factor Xa activity in umbilical cord vein samples after subcutaneous administration of heparin or low molecular mass heparin in pregnant women
Abstract
Prophylaxis of thromboembolism with low molecular mass (LMM) heparin may offer several advantages over conventional heparin during pregnancy. Heparin-related side effects as osteoporosis, local allergy, thrombocytopenia and increase in liver enzymes may occur less frequently with LMM heparin. However, LMM heparins of different origins have to be considered as individual pharmaceutical compounds. This is of special clinical importance regarding a possible placental passage. We performed a randomized controlled study comparing the anti-factor Xa activities in plasma samples of 60 pregnant women undergoing delivery at term and in the umbilical cord vein of the newborn after subcutaneous administration of 5,000 IU unfractionated (UF) heparin or 1,500 activated partial thromboplastin time units LMM heparin or placebo. Injections were performed about 2 h prior to the delivery. Maternal and fetal blood samples were taken at the same time to assay heparin activity by the heptest coagulation assay and the S2222 chromogenic substrate method. LMM heparin was detected in all maternal plasma samples whereas UF heparin was measurable only in about one third of them. UF heparin as well as LMM heparin were not detectable in samples taken from the umbilical cord vein. The data demonstrate that neither UF nor the LMM heparin used in this study cross the placenta in relevant inhibitory activity towards factor Xa. This finding is in accordance with the previous experiences regarding the safe administration of other LMM heparins for prophylaxis of thromboembolism during pregnancy.
Similar articles
-
Monitoring of heparins in haemodialysis using an anti-factor-Xa-specific whole-blood clotting assay.Nephrol Dial Transplant. 1995;10(2):217-22. Nephrol Dial Transplant. 1995. PMID: 7753456 Clinical Trial.
-
[Placental transfer of low-molecular weight heparin].Geburtshilfe Frauenheilkd. 1995 Feb;55(2):93-8. doi: 10.1055/s-2007-1022782. Geburtshilfe Frauenheilkd. 1995. PMID: 7758899 Clinical Trial. German.
-
Comparison of low molecular weight heparins and unfractionated heparin after successive subcutaneous administration. A randomized controlled study in healthy volunteers.Arzneimittelforschung. 1993 May;43(5):542-7. Arzneimittelforschung. 1993. PMID: 8392345 Clinical Trial.
-
Low molecular weight heparin use during pregnancy: issues of safety and practicality.Obstet Gynecol Surv. 1999 Oct;54(10):649-54. doi: 10.1097/00006254-199910000-00022. Obstet Gynecol Surv. 1999. PMID: 10511964 Review.
-
Anticoagulant choices in pregnant women with mechanical heart valves: balancing maternal and fetal risks--the difference the dose makes.Thromb Res. 2013 Jan;131 Suppl 1:S8-10. doi: 10.1016/S0049-3848(13)70010-0. Thromb Res. 2013. PMID: 23452748 Review.
Cited by
-
Thrombophilia and pregnancy.Reprod Biol Endocrinol. 2003 Nov 14;1:111. doi: 10.1186/1477-7827-1-111. Reprod Biol Endocrinol. 2003. PMID: 14617365 Free PMC article. Review.
-
Thrombophilia and its treatment in pregnancy.J Thromb Thrombolysis. 2001 Sep;12(1):23-30. doi: 10.1023/a:1012730325902. J Thromb Thrombolysis. 2001. PMID: 11711685 Review.
-
Anticoagulation for mechanical heart valves in patients with and without atrial fibrillation.Curr Cardiol Rep. 2010 Mar;12(2):133-9. doi: 10.1007/s11886-010-0085-x. Curr Cardiol Rep. 2010. PMID: 20425168 Review.
-
Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period.Cochrane Database Syst Rev. 2021 Mar 29;3(3):CD001689. doi: 10.1002/14651858.CD001689.pub4. Cochrane Database Syst Rev. 2021. PMID: 33779986 Free PMC article.
-
Low molecular weight heparins: a guide to their optimum use in pregnancy.Drugs. 2002;62(3):463-77. doi: 10.2165/00003495-200262030-00004. Drugs. 2002. PMID: 11827560 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical